- Home
- VACI vs ANL Comparison
VACI vs ANL Comparison
Compare VACI & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$9.96
Company Overview
Basic Information| Metric | VACI | ANL |
|---|---|---|
| Founded | 2025 | 2004 |
| Country | United States | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | |
| Sector | Telecommunications | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 310.8M | 350.9M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | VACI | ANL |
|---|---|---|
| Price | $9.96 | $9.00 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $16.00 |
| AVG Volume (30 Days) | 75.1K | ★ 214.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.86 | $0.88 |
| 52 Week High | $10.07 | $12.09 |
Technical Indicators
Market Signals| Indicator | VACI | ANL |
|---|---|---|
| Relative Strength Index (RSI) | 52.24 | 55.38 |
| Support Level | $9.94 | $1.37 |
| Resistance Level | $9.97 | $10.15 |
| Average True Range (ATR) | 0.02 | 0.97 |
| MACD | -0.00 | -0.27 |
| Stochastic Oscillator | 60.00 | 56.12 |
Price Performance
Historical Comparison VACI
ANL
About VACI Viking Acquisition Corp. I Class A Ordinary Shares
Viking Acquisition Corp I is a blank check company.
About ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.